Assuntos
Doenças Musculoesqueléticas/terapia , Avaliação de Resultados em Cuidados de Saúde , Custos de Cuidados de Saúde , Humanos , Morbidade , Doenças Musculoesqueléticas/economia , Doenças Musculoesqueléticas/epidemiologia , Guias de Prática Clínica como Assunto , Padrões de Prática Médica , Qualidade da Assistência à SaúdeRESUMO
Benjamin Franklin would have been an excellent physiatrist. In this short address, I explore the qualities that Franklin possessed in the medical realm. Several ways in which we can emulate some of his traits to become better physiatrists are proposed.
Assuntos
Pessoas Famosas , Medicina Física e Reabilitação/história , História do Século XVIII , Humanos , Masculino , Pesquisa/história , Estados UnidosRESUMO
OBJECTIVE: To report inpatient rehabilitation outcome in severe cases of West Nile virus (WNV) infection. DESIGN: Retrospective case series. SETTING: Freestanding rehabilitation hospital. PARTICIPANTS: Five consecutive patients admitted to an inpatient rehabilitation hospital with proven WNV infection. PATIENTS: had severe neurologic manifestations and functional deficits. INTERVENTIONS: Not applicable. MAIN OUTCOME MEASURE: FIM instrument scores. RESULTS: On admission, overall FIM scores ranged from 31 to 68, with a mean of 44.40+/-15.85; overall FIM scores ranged from 52 to 90, with a mean of 76.00+/-15.03 at discharge. CONCLUSIONS: All patients demonstrated significant functional improvement ( P <.001). Length of stay ranged from 10 to 71 days, with a mean of 32 days. Lower functional outcome and higher cost of care were noted in patients and was attributable to severe muscle weakness and axonal neuropathy.
Assuntos
Febre do Nilo Ocidental/reabilitação , Adulto , Idoso , Comorbidade , Feminino , Hospitalização/economia , Humanos , Masculino , Pessoa de Meia-Idade , Centros de Reabilitação , Estudos Retrospectivos , Resultado do Tratamento , Febre do Nilo Ocidental/fisiopatologiaRESUMO
OBJECTIVE: This study was undertaken to test the hypothesis that intramuscular botulinum toxin type A decreases chronic pain attributed to piriformis muscle syndrome to a greater extent than a similar injection with vehicle (saline) alone. DESIGN: This double-blind, single group, crossover study was performed at an outpatient university clinic. Nine women with chronic buttock, hip, and lower limb pain without evidence of lumbar disk herniation or nerve root impingement on imaging studies participated in the study. The analgesic efficacy of a fluoroscopic/electromyographically guided unilateral intramuscular piriformis injection with 100 units botulinum toxin type A was compared with a similar injection of vehicle alone. Visual analog pain scales (VASs) were used to measure pain intensity, distress, spasm, and interference with activities. RESULTS: No differences in mean VASs were detected between groups at baseline or after injection with vehicle. However, decreases were observed between baseline and post-botulinum toxin type A injection mean VASs, but only in one of four categories (interference with activities). VASs from every time point (days) were also compared with the average baseline VASs. After injection with vehicle, decreases were detected, but only in one of the four categories (distress). In comparison, after injection with botulinum toxin type A, decreases were observed under all VAS categories. CONCLUSIONS: VAS data suggest that intramuscular piriformis injection with 100 units of botulinum toxin type A can reduce pain to a greater extent than similar injections with vehicle alone.